1
2
#OpenInnovation
3
4
News & Events
Merck to buy Xeraya-backed Imago BioSciences for $1.35b
November 22, 2022
Xeraya first invested in the company in May 2019. Read more
Nobel Prize goes to click chemists who discovered how to snap molecules together
October 5, 2022
Carolyn R. Bertozzi, Morten Meldal and K. Barry Sharpless became Nobel laureates. Read more
Allecra Therapeutics Publishes Final Phase 3 ALLIUM Data in JAMA
October 5, 2022
Cefepime/Enmetazobactam met criteria for superiority. Read more
5
#knowledgebase
6
7
News & Events
Merck to buy Xeraya-backed Imago BioSciences for $1.35b
November 22, 2022
Xeraya first invested in the company in May 2019. Read more
Nobel Prize goes to click chemists who discovered how to snap molecules together
October 5, 2022
Carolyn R. Bertozzi, Morten Meldal and K. Barry Sharpless became Nobel laureates. Read more
Allecra Therapeutics Publishes Final Phase 3 ALLIUM Data in JAMA
October 5, 2022
Cefepime/Enmetazobactam met criteria for superiority. Read more
8
Portfolio Highlights
#PharmaBiotech
11
Our View
10
Our Focus
12
#PRI
22
Medical Technologies
#Portfolio
14
Championing
collaborations
that improve health
and the quality of life
for everyone.
#JoinForces
#LifeSciencesInTheFuture
16
Words from
the CEO
17
Portfolio Highlights
#PharmaBiotech
28
Pharmaceutical Biotech
#Portfolio
15
About Us
34
Biorenewables & Others
#Portfolio
19
WHAT'S TRENDING @ XERAYA
Merck to buy Imago BioSciences for $1.35b
20
Our Team
21
23
Portfolio Highlights
#Biorenewables
30
Portfolio Highlights
#MedTech
25
26
ARE YOU
The Next
Big Thing?
Submit
A
Proposal
29
36
Career
#Xeraya
35
37
News & Events
Merck to buy Xeraya-backed Imago BioSciences for $1.35b
November 22, 2022
Xeraya first invested in the company in May 2019. Read more
Nobel Prize goes to click chemists who discovered how to snap molecules together
October 5, 2022
Carolyn R. Bertozzi, Morten Meldal and K. Barry Sharpless became Nobel laureates. Read more
Allecra Therapeutics Publishes Final Phase 3 ALLIUM Data in JAMA
October 5, 2022
Cefepime/Enmetazobactam met criteria for superiority. Read more
32
#agro
33
Portfolio Highlights
#Biorenewables
38
Portfolio Highlights
#MedTech
39
40
Contact Us
41
